P

Inventor

EMGENBROICH MARCO

DE13 patents
⚠️ This page may combine multiple inventors who share the name “EMGENBROICH MARCO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LTS LOHMANN THERAPIE SYSTEME AG

12 patents
US11576874B2Feb 14, 2023

Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymer

LTS LOHMANN THERAPIE SYSTEME AG4 citations70
US12070521B2Aug 27, 2024

Method for adjusting the release of active agent in a transdermal delivery system

LTS LOHMANN THERAPIE SYSTEME AG0 citations59
US11426359B2Aug 30, 2022

Method for adjusting the release of active agent in a transdermal delivery system

LTS LOHMANN THERAPIE SYSTEME AG0 citations59
US12214088B2Feb 4, 2025

Transdermal therapeutic system for the transdermal administration of guanfacine comprising at least one additive

LTS LOHMANN THERAPIE SYSTEME AG0 citations58
US12168074B2Dec 17, 2024

Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymer

LTS LOHMANN THERAPIE SYSTEME AG0 citations58
US12048770B2Jul 30, 2024

Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone acrylic hybrid polymer

LTS LOHMANN THERAPIE SYSTEME AG0 citations58
US12427119B2Sep 30, 2025

Transdermal delivery system including an interface mediator

LTS LOHMANN THERAPIE SYSTEME AG0 citations53
US11752110B2Sep 12, 2023

Transdermal delivery system including an interface mediator

LTS LOHMANN THERAPIE SYSTEME AG0 citations53
US11198800B2Dec 14, 2021

Control of adhesive domains

LTS LOHMANN THERAPIE SYSTEME AG0 citations49
US11633367B2Apr 25, 2023

Transdermal delivery system containing rotigotine

LTS LOHMANN THERAPIE SYSTEME AG0 citations46
US11389410B2Jul 19, 2022

Multi-day patch for the transdermal administration of rotigotine

LTS LOHMANN THERAPIE SYSTEME AG0 citations44
US11389421B2Jul 19, 2022

Transdermal therapeutic system for the transdermal administration of rivastigmine

LTS LOHMANN THERAPIE SYSTEME AG0 citations41

SELLERGREN BÖRJE

1 patent